Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBILB.L Regulatory News (BILB)

  • There is currently no data for BILB

Trading update

1 Aug 2019 07:00

RNS Number : 4686H
Bilby PLC
01 August 2019
 

1 August 2019

Bilby plc

("Bilby", the "Group" or the "Company")

 

Trading update

 

Bilby Plc, a leading gas heating, electrical and building services provider, announces the following trading and operational update.

 

Further to the announcement on 5 March 2019, the Board continues to expect to report positive underlying EBITDA of between £2.0 to £3.0 million for the year ending 31 March 2019.

 

The Board has been engaged in a comprehensive operational and financial review of the business that has accelerated with the appointment of David Bullen as Chief Executive Officer in April 2019. This review remains ongoing. However, initial work undertaken as part of the review has conclusively established that the Group's loss-making activities have been isolated to historical management failings in the Group's subsidiary company, P&R where, as previously announced, the Group has been materially impacted by two major contracts (the "Disputed Contracts"). Further information on the Disputed Contracts is set out below.

 

In July 2019, the Group closed P&R's gas servicing division and restructured all ongoing profitable building services contracts to be serviced under the management responsibility of the Group's subsidiary Purdy. This action has eliminated the losses from the division.

 

The other four businesses within the Group continue to trade in line with management expectations and the Board remains confident in their outlook.

 

As previously reported, the Group terminated P&R's contract with Amey to provide building services to Ministry of Defence properties in May 2018. The major gas contract with East Kent Housing was also terminated by the Group in April 2019. The Group initiated formal resolution proceedings with both organisations to recover disputed money owed. Bilby continues to vigorously defend its position in relation to services provided and work undertaken and invoiced in respect of these Disputed Contracts. However, any outcome will be finalised through an independent adjudication process. The Board anticipates material restructuring costs and write offs associated with the Disputed Contracts for the year ended 31 March 2019. The Group has recently received part payment from one of the Disputed Contracts.

 

As a consequence of the ongoing resolution proceedings related to the Disputed Contacts and with the intention to report in more detail on their outcome, Bilby now anticipates releasing its financial results for the year ended 31 March 2019 in early September 2019.

 

 

 

Enquiries

 

Bilby plc

 

David Bullen, Chief Executive

 

 

+44 (0)20 7796 4133

(via Hudson Sandler)

 

 

Canaccord Genuity Ltd (Nominated Adviser and Joint Broker)

+44 (0)20 7523 8000

Corporate Broking:

Bobbie Hilliam

Georgina McCooke

Sales:

Jonathan Barr

 

 

 

Stanford Capital Partners (Joint Broker)

John Howes/ Bob Pountney

+44 (0)20 3815 8880

 

 

 

Hudson Sandler (Financial PR)

 

+44 (0)20 7796 4133

Charlie Jack

Bertie Berger

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSDLEFFFUSESW
Date   Source Headline
16th Jun 20214:46 pmRNSChange of name to Kinovo plc
24th May 20216:12 pmRNSDirector/PDMR Shareholding
12th May 20214:57 pmRNSDirector/PDMR Shareholding
6th May 202110:09 amRNSHolding(s) in Company
6th May 20217:00 amRNSYear-end trading update
15th Apr 20214:41 pmRNSSecond Price Monitoring Extn
15th Apr 20214:35 pmRNSPrice Monitoring Extension
30th Mar 20217:00 amRNSDirector/PDMR Shareholding
23rd Mar 20214:16 pmRNSHolding(s) in Company
18th Mar 20212:01 pmRNSHolding(s) in Company
12th Mar 20214:41 pmRNSSecond Price Monitoring Extn
12th Mar 20214:36 pmRNSPrice Monitoring Extension
11th Mar 20219:37 amRNSHolding(s) in Company
11th Mar 20219:11 amRNSDirector/PDMR Shareholding and Share Plan
8th Feb 20214:49 pmRNSHolding(s) in Company
28th Jan 20213:58 pmRNSHolding(s) in Company
24th Dec 20207:00 amRNSJoint Share Ownership Plan
1st Dec 20207:00 amRNSHalf Year results
13th Nov 20207:00 amRNSTrading update and Board restructure
14th Oct 20204:40 pmRNSHolding(s) in Company
12th Oct 20208:15 amRNSHolding(s) in Company
5th Oct 202011:04 amRNSReplacement: Holding(s) in Company
30th Sep 202011:33 amRNSHolding(s) in Company
30th Sep 202011:28 amRNSHolding(s) in Company
16th Sep 20206:07 pmRNSDirector/PDMR Shareholding
14th Sep 202011:34 amRNSResult of AGM
11th Sep 202010:07 amRNSBoard change
14th Aug 202011:08 amRNSHolding(s) in Company
14th Aug 202010:35 amRNSAnnual Report and Notice of AGM
27th Jul 20201:27 pmRNSHolding(s) in Company
27th Jul 20207:00 amRNSFull Year Results
16th Jul 20207:00 amRNSNotice of Results
26th May 20208:06 amRNSNew Banking Facilities
7th May 20207:00 amRNSDirector/PDMR Shareholding
28th Apr 20203:44 pmRNSDirector/PDMR Shareholding
24th Apr 20207:00 amRNSYear-end and COVID-19 trading update
1st Apr 20204:41 pmRNSSecond Price Monitoring Extn
1st Apr 20204:36 pmRNSPrice Monitoring Extension
11th Mar 20203:41 pmRNSDirector/PDMR Shareholding
19th Dec 20197:00 amRNSInterim Results
3rd Dec 20194:48 pmRNSNotice of Results
25th Nov 20197:00 amRNSDirectorate Change
22nd Nov 20197:00 amRNSHolding(s) in Company
21st Nov 201912:07 pmRNSHolding(s) in Company
20th Nov 20195:40 pmRNSHolding(s) in Company
20th Nov 20194:40 pmRNSHolding(s) in Company
15th Nov 20198:02 amRNSResult of Fundraise
14th Nov 20194:52 pmRNSProposed Fundraise
28th Oct 20194:21 pmRNSResult of Annual General Meeting
30th Sep 201911:59 amRNSAnnual Report and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.